Anthea J. Stanley

1.3k total citations
21 papers, 851 citations indexed

About

Anthea J. Stanley is a scholar working on Molecular Biology, Spectroscopy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anthea J. Stanley has authored 21 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Spectroscopy and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anthea J. Stanley's work include Advanced Proteomics Techniques and Applications (10 papers), Renal cell carcinoma treatment (5 papers) and Mass Spectrometry Techniques and Applications (5 papers). Anthea J. Stanley is often cited by papers focused on Advanced Proteomics Techniques and Applications (10 papers), Renal cell carcinoma treatment (5 papers) and Mass Spectrometry Techniques and Applications (5 papers). Anthea J. Stanley collaborates with scholars based in United Kingdom, Australia and Germany. Anthea J. Stanley's co-authors include Rosamonde E. Banks, Peter J. Selby, David A. Cairns, Douglas Thompson, Jennifer H. Barrett, Patricia Harnden, Paul A. Clarke, Margaret A. Knowles, Adrian Joyce and Eamonn R. Maher and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Anthea J. Stanley

21 papers receiving 837 citations

Peers

Countries citing papers authored by Anthea J. Stanley

Since Specialization

Citations

This map shows the geographic impact of Anthea J. Stanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthea J. Stanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthea J. Stanley more than expected).

Fields of papers citing papers by Anthea J. Stanley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthea J. Stanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthea J. Stanley. The network helps show where Anthea J. Stanley may publish in the future.

Co-authorship network of co-authors of Anthea J. Stanley

This figure shows the co-authorship network connecting the top 25 collaborators of Anthea J. Stanley. A scholar is included among the top collaborators of Anthea J. Stanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthea J. Stanley. Anthea J. Stanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease 2011 ·PROTEOMICS - CLINICAL APPLICATIONS ·Douglas Thompson, (unknown), David A. Cairns, Jennifer H. Barrett, David Perkins, Anthea J. Stanley, Andrew Mooney, Peter J. Selby, Rosamonde E. Banks	5
2	Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma 2009 ·British Journal of Cancer ·Naveen Vasudev, (unknown), David A. Cairns, Roisean E. Ferguson, Rachel A. Craven, Anthea J. Stanley, (unknown), Douglas Thompson, Peter J. Selby, Rosamonde E. Banks	24
3	Changes in the urinary proteome post‐operatively in renal cancer patients – a reflection of tumour or kidney removal? 2009 ·PROTEOMICS - CLINICAL APPLICATIONS ·(unknown), David A. Cairns, David N. Perkins, Jianhe Peng, Anthea J. Stanley, Douglas Thompson, Andrew Lewington, Peter J. Selby, Rosamonde E. Banks	3
4	Using the protein chip interface with quadrupole time‐of‐flight mass spectrometry to directly identify peaks in SELDI profiles – initial evaluation using low molecular weight serum peaks 2009 ·PROTEOMICS ·Jianhe Peng, Anthea J. Stanley, David A. Cairns, Peter J. Selby, Rosamonde E. Banks	15
5	Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison 2008 ·PROTEOMICS ·David A. Cairns, Jennifer H. Barrett, Lucinda Billingham, Anthea J. Stanley, George Xinarianos, John K. Field, Phillip J. Johnson, Peter J. Selby, Rosamonde E. Banks	48
6	Serum biomarker discovery in renal cancer using 2‐DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same? 2008 ·PROTEOMICS ·Naveen Vasudev, Roisean E. Ferguson, David A. Cairns, Anthea J. Stanley, Peter J. Selby, Rosamonde E. Banks	26
7	Integrated multi-level quality control for proteomic profiling studies using mass spectrometry 2008 ·BMC Bioinformatics ·David A. Cairns, David N. Perkins, Anthea J. Stanley, Douglas Thompson, Jennifer H. Barrett, Peter J. Selby, Rosamonde E. Banks	20
8	An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer 2008 ·European Journal of Cancer ·Poulam M. Patel, (unknown), (unknown), Andrew Protheroe, (unknown), Anthea J. Stanley, J.M. Tourani, D. Khayat, Barry W. Hancock, P. Vasey, Angus Dalgleish, C.F. Johnston, Rosamonde E. Banks, Peter J. Selby	32
9	Proteomic profiling using mass spectrometry – does normalising by total ion current potentially mask some biological differences? 2007 ·PROTEOMICS ·David A. Cairns, Douglas Thompson, David N. Perkins, Anthea J. Stanley, Peter J. Selby, Rosamonde E. Banks	25
10	Genetic and Epigenetic Analysis of von Hippel-Lindau ( VHL ) Gene Alterations and Relationship with Clinical Variables in Sporadic Renal Cancer 2006 ·Cancer Research ·Rosamonde E. Banks, Prasanna Tirukonda, Claire Taylor, Nick Hornigold, Dewi Astuti, D. Cohen, Eamonn R. Maher, Anthea J. Stanley, Patricia Harnden, Adrian Joyce, Margaret A. Knowles, Peter J. Selby	214
11	Urinary biomarker profiling in transitional cell carcinoma 2006 ·International Journal of Cancer ·Nicholas P. Munro, David A. Cairns, Paul A. Clarke, Mark A. Rogers, Anthea J. Stanley, Jennifer H. Barrett, Patricia Harnden, Douglas Thompson, Ian Eardley, Rosamonde E. Banks, Margaret A. Knowles	60
12	Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma 2006 ·PROTEOMICS ·Rachel A. Craven, Anthea J. Stanley, Sarah Hanrahan, (unknown), Richard D. Unwin, Nick Totty, Patricia Harnden, Ian Eardley, Peter J. Selby, Rosamonde E. Banks	62
13	Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma 2006 ·PROTEOMICS ·Rachel A. Craven, Sarah Hanrahan, Nick Totty, Patricia Harnden, Anthea J. Stanley, Eamonn R. Maher, Adrian L. Harris, William S. Trimble, Peter J. Selby, Rosamonde E. Banks	50
14	Intrinsic chemotherapy resistance to the tubulin‐binding antimitotic agents in renal cell carcinoma 2005 ·International Journal of Cancer ·Roisean E. Ferguson, Sharon M. Jackson, Anthea J. Stanley, Adrian Joyce, Patricia Harnden, Ewan E. Morrison, Poulam M. Patel, Roger M. Phillips, Peter J. Selby, Rosamonde E. Banks	25
15	Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I β-Tubulin Gene but Changes in Tubulin Isotype Protein Expression 2005 ·Clinical Cancer Research ·Roisean E. Ferguson, Claire Taylor, Anthea J. Stanley, Elizabeth Butler, Adrian Joyce, Patricia Harnden, Poulam M. Patel, Peter J. Selby, Rosamonde E. Banks	21
16	Identification of proteins regulated by interferon‐α in resistant and sensitive malignant melanoma cell lines 2004 ·PROTEOMICS ·Rachel A. Craven, Anthea J. Stanley, Sarah Hanrahan, Nick Totty, David Jackson, Răzvan Popescu, Allen Taylor, Jürgen Frey, Peter J. Selby, Poulam M. Patel, Rosamonde E. Banks	12
17	Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule 2001 ·Cancer Immunology Immunotherapy ·Anthea J. Stanley, Michael J. Gough, Rosamonde E. Banks, (unknown), Poulam M. Patel	10
18	Production and Characterization of Monoclonal Antibodies to Human Interleukin-12 1997 ·Hybridoma ·(unknown), Poulam M. Patel, Anthea J. Stanley, Eileen Ingham, Meenu Wadhwa, Chris Bird, Robin Thorpe, Peter J. Selby, Rosamonde E. Banks	3
19	Effect of cell density on the expression of adhesion molecules and modulation by cytokines 1995 ·Cytometry ·Anthea J. Stanley, Rosamonde E. Banks, Jennifer Southgate, P Selby	14
20	Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II study. 1993 ·PubMed ·Anthea J. Stanley, Raffi Kaprielian, Spyros Retsas	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact